HK StockDetailed Quotes

Provided by TTMF Limited

IMPACT THERAP-BUnlisted

Volume:- -

Turnover:- -

Market Cap:- -

PE:- -

High:- -

Open:- -

Low:- -

Close:- -

52wk High:- -

52wk Low:- -

Shares:234.00M

HK Float Shares:234.00M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

PS:- -

1

Offering

May 05

2

Closed

May 08 10:15

3

IPO Result

May 11

4

Grey Mkt.

May 12 16:15 - 18:30

5

Listing

May 13

Overview Company News Filings

Price Range

19.75 ~ 21.75 HKD

Listing Price

- -

Issue Volume

41.98M

Estimated Mkt Cap

5.45B ~ 6.01B HKD

Min Amount

200

Underwrither

Goldman Sachs (Asia) L.L.C.

View Prospectus

News

Hong Kong Stocks Slump As Middle East Fighting Escalates

MT Newswires Live

Impact Therapeutics Launches Up to HK$913 Million Hong Kong IPO

MT Newswires Live

BRIEF-Impact Therapeutics Launches Global Offering Of 42 Mln H Shares

Impact Therapeutics启动香港上市全球发售，最高发售价每股21.75港元，一手入场费约4,393.88港元

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/07630"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"07630","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07630\",,,,,undefined,":{"symbol":"07630","market":"HK","secType":"STK","nameCN":"IMPACT THERAP-B","latestPrice":0,"timestamp":1778054400000,"preClose":0,"halted":7,"volume":0,"delay":0,"floatShares":234000000,"shares":234000000,"eps":0,"marketStatus":"To be listed","change":0,"latestTime":"05-06 16:00:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1778635800000},"marketStatusCode":8,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1778031000000,1778040000000],[1778043600000,1778054400000]],"volumeRatio":0,"ipoDetail":{"name":"英派药业－Ｂ","exchange":"SEHK","listingDate":"2026-05-13","sharesOutstanding":276165130,"sharesFloat":276165130,"offerAmount":41977000,"priceRange":"19.750 - 21.750","market":"HK","openProspectusDate":"2026-05-05","openProspectusUrl":"https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0505/2026050500024_c.pdf","purchaseBeginDate":"2026-05-05","purchaseEndDate":"2026-05-08","winningDate":"2026-05-12","currency":"HKD","minPurchaseQuantity":200,"peRate":-17.52,"use":"1、约51%或398.37百万港元将用于为核心产品塞纳帕利正在进行及计划中的临床开发、监管批准以及商业化提供资金；\n2、约31%或242.15百万港元将用于为关键产品IMP1734及IMP9064正在进行的临床开发提供资金；\n3、约8%或62.49百万港元将用于为其他管线资产、IMP1707、IMP7068、IMP22、IMP25、IMP08、IMP13及IMP10的研发活动提供资金；\n4、约8%或62.49百万港元将用于为研发平台的开发及扩大药物管线提供资金；\n5、约2%或15.62百万港元将用于营运资金及其他一般公司用途。","industryId":"204005","industryName":"医疗保健","business":"公司是一家处于商业化阶段的创新驱动型生物技术公司，致力于在全球范围内推进基于合成致死(synthetic lethality)机制的精准抗癌疗法，打造创新疗法，以满足癌症患者未被满足的医疗需求。公司自主研发的核心产品塞纳帕利已在中国获批上市，作为卵巢癌一线维持疗法，适用于全人群（无论突变状态），并展现出令人信服的临床特征。通过整合小分子药物与新兴疗法（包括新型抗体偶联药物和蛋白降解剂）的自主研发平台，公司持续推动创新突破。","subscribed":86.91,"marketCap":5454000000,"minimumCapital":4393.88,"overAllotment":true,"lotSize":200,"issueOpenRate":0.1,"subscribeGear":"200,400,600,800,1000,1200,1400,1600,1800,2000,3000,4000,5000,6000,7000,8000,9000,10000,20000,30000,40000,50000,60000,70000,80000,90000,100000,200000,300000,400000,500000,600000,700000,800000,900000,1000000,1250000,1500000,1750000,2098800","issueRatio":0.1,"offeringMechanism":"B"},"greyMarketDetail":{"greyDate":"2026-05-12","greyDateTimestamp":1778515200000,"greyOpeningTime":1778573700000,"greyClosingTime":1778581800000,"showGreyQuote":false,"openProspectusDate":"2026-05-05","listingDate":"2026-05-13"},"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07630\",,,,,undefined,":{"symbol":"07630","floatShares":234000000,"roa":"--","roe":"--","lyrEps":0,"shares":234000000,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"https://hktrade.skytigris.com/ipos/general/07630\",,undefined,":{"id":9966,"type":"COMMON","ipoName":"07630-IPO","symbol":"07630","companyName":"IMPACT THERAP-B","market":"HK","currency":"HKD","status":"OPEN","underwriter":"Goldman Sachs (Asia) L.L.C.","lotSize":200,"minQty":200,"expectedOfferingSize":41977000,"openingDate":1777944600000,"closingDate":1778206500000,"commonClosingDate":1778206500000,"allotmentDate":1778428800000,"listDate":1778601600000,"marginable":true,"marginRate":10,"latestPrice":21.75,"minPrice":19.75,"maxPrice":21.75,"prospectusUrl":"https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0505/2026050500023.pdf","allowedQuantities":[200,400,600,800,1000,1200,1400,1600,1800,2000,3000,4000,5000,6000,7000,8000,9000,10000,20000,30000,40000,50000,60000,70000,80000,90000,100000,200000,300000,400000,500000,600000,700000,800000,900000,1000000,1250000,1500000,1750000,2098800],"interestRate":0,"recommend":false,"isHint":false,"interestStartDate":1778169600000,"interestEndDate":1778342400000,"delayAllocate":false,"isSupportGreyMarket":true,"greyMarketTradeDate":1778573700000,"transactionRate":0.010085,"gstFeeRate":0,"rank":0,"subscribed":false,"signed":false,"financingInfos":[{"ipoName":"07630-IPO","ipoId":9966,"financingId":59526,"type":1,"availableFundLimit":4393.86,"piAvailableAmountLimit":0,"piMaxAvailableAmountLimit":-1,"piMinSubscribeAmount":0,"piMaxSubscribeAmount":-1,"minSubscribeLimit":43938.6,"maxSubscribeLimit":-1,"marginRate":10,"interestRate":0,"openTime":1777944600000,"closeTime":1778206500000,"isAtValidTime":true,"subscriptionMethod":"FINANCING","processFee":0,"supportPI":false,"applyFundLimit":4393.86,"threshold":50000000000,"isAvailable":false},{"ipoName":"07630-IPO","ipoId":9966,"financingId":59519,"type":4,"availableFundLimit":4393.86,"piAvailableAmountLimit":0,"piMaxAvailableAmountLimit":-1,"piMinSubscribeAmount":0,"piMaxSubscribeAmount":-1,"minSubscribeLimit":0,"maxSubscribeLimit":-1,"marginRate":100,"interestRate":0,"openTime":1777944600000,"closeTime":1778206500000,"isAtValidTime":true,"subscriptionMethod":"CASH","processFee":0,"supportPI":false,"applyFundLimit":4393.86,"threshold":50000000000,"isAvailable":false}],"financingNotifyEnabled":false,"financingNotifySubscribed":false,"subscriptionMethods":[{"method":"FINANCING","closeTime":1778206500000,"available":false,"messageCode":"AVAILABLE_FUND_LIMIT","minAvailableFundLimit":4393.86},{"method":"CASH","closeTime":1778206500000,"available":false,"messageCode":"AVAILABLE_FUND_LIMIT","minAvailableFundLimit":4393.86}],"latestClosingDate":1778206500000,"subscribedFinanceRatio":86.91,"subscribedRatio":86.91,"forecastRatio":118.2,"raiseMoney":91300000,"totalMargin":7935490000,"quoteInfoUpdatedAt":1778100078473,"prospectusUpdatedAt":1778048316000,"forecastMarketValue":5730426447.5,"minForecastMarketValue":5454261317.5,"maxForecastMarketValue":6006591577.5,"sharesOutstanding":276165130,"business":"公司是一家处于商业化阶段的创新驱动型生物技术公司，致力于在全球范围内推进基于合成致死(synthetic lethality)机制的精准抗癌疗法，打造创新疗法，以满足癌症患者未被满足的医疗需求。公司自主研发的核心产品塞纳帕利已在中国获批上市，作为卵巢癌一线维持疗法，适用于全人群（无论突变状态），并展现出令人信服的临床特征。通过整合小分子药物与新兴疗法（包括新型抗体偶联药物和蛋白降解剂）的自主研发平台，公司持续推动创新突破。","greyOpeningTime":1778573700000,"greyClosingTime":1778581800000,"tradable":true,"showClawback":true,"clawbackType":"Mechanism B","clawbackRate":10},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"07630\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633918111","title":"Hong Kong Stocks Slump As Middle East Fighting Escalates","url":"https://stock-news.laohu8.com/highlight/detail?id=2633918111","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633918111?lang=en_us&edition=fundamental","pubTime":"2026-05-05 16:40","pubTimestamp":1777970423,"startTime":"0","endTime":"0","summary":"Hong Kong equities fell Tuesday as bearish sentiment prevailed amid escalating tensions in the Middle East.The Hang Seng Index fell by around 197.27 points, or roughly 0.8%, to end at 25,898.61, while","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HHImain","HSTECH","07630","01609","HSI","MCHmain","02833","07666","MHImain","513600","BK1148","HSCCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633159998","title":"Impact Therapeutics Launches Up to HK$913 Million Hong Kong IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2633159998","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633159998?lang=en_us&edition=fundamental","pubTime":"2026-05-05 09:42","pubTimestamp":1777945328,"startTime":"0","endTime":"0","summary":"Impact Therapeutics (HKG:7630) launched its Hong Kong initial public offering on Tuesday, seeking to raise up to about HK$913 million from the deal.The China-based biotechnology company is offering 42","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IPOS","BK4539","BK4139","BK4007","07630","LENZ","SPCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633999861","title":"BRIEF-Impact Therapeutics Launches Global Offering Of 42 Mln H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2633999861","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633999861?lang=en_us&edition=fundamental","pubTime":"2026-05-05 09:33","pubTimestamp":1777944795,"startTime":"0","endTime":"0","summary":"BRIEF-Impact Therapeutics Launches Global Offering Of 42 Mln H SharesMay 5  - Impact Therapeutics 7630.HK:GLOBAL OFFERING OF 42 MILLION H SHARESMAXIMUM OFFER PRICE UNDER GLOBAL OFFERING HK$21.75 PER H SHARENUMBER OF INTERNATIONAL OFFER SHARES OF 37.8 MILLION H SHARES UNDER GLOBAL OFFERINGFurther company coverage: [ ] ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nFWN41H0X0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135046472","title":"Impact Therapeutics启动香港上市全球发售，最高发售价每股21.75港元，一手入场费约4,393.88港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1135046472","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135046472?lang=en_us&edition=fundamental","pubTime":"2026-05-05 06:30","pubTimestamp":1777933851,"startTime":"0","endTime":"0","summary":"一、公司概况   Impact...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Impact Therapeutics启动香港上市全球发售，最高发售价每股21.75港元，一手入场费约4,393.88港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}]}}